ETF STRATEGIES
Improve Your ETF Trading
ETF PowerRatings: New ETF Strategies for the ETF Market
If you've been looking for a way to get into the ETF market, then ETF PowerRatings may be the most important trading resource you access this year.

Lock in the Gains: ETF Trading Strategies for Short Term Traders

Learn How to Trade ETF Funds Successfully: TPS and the Science of Scaling-In

Moving Averages: ETF Strategies for Short Term Traders

Receive Alerts
Free

For One Week!
Stock PowerRatings
Use PowerRatings every day to find the stocks for tomorrow to focus on and the ones to avoid. Sign Up Now >>

ETF PowerRatings
Use PowerRatings to find the ETFS to focus on to build your portfolio for ETF gains.
Sign Up Now >>

Gary Kaltbaum Intraday Breaking Setups
Let Gary Kaltbaum send you timely emails to alert you when breakouts occur.
Sign Up Now >>

Kevin Haggerty's Professional Trading Service
Every day receive the best plan of attack for the next day's trading directly from professional trader Kevin Haggerty.
Sign Up Now >>
awards
TradingMarkets AS SEEN ON...
Yahoo! Finance (content partner)
Forbes.com (content partner)
AOL Money (content partner)
CNBC
Fox Business News
Bloomberg TV
Wall Street Journal
MarketWatch
Fortune
New York Times
Stocks and Commodities
Active Trader Magazine
Los Angeles Times
Futures Magazine
Barrons
Reuters
SFO Magazine
Investor's Edge
E*Trade Radio
Bloomberg Markets Magazine
Chicago Mercantile Exchange
Forbes.com
SFO
Registered Rep
FXstreet.com

  Results matching symbol: IMGN

BiomedReports: News and FDA Updates for ForeverGreen (OTC:FVRG), Hercules Technology (NASDAQ:HTGC), ImmunoGen (Nasdaq:IMGN)

March 19, 2010
Pasadena, CA, Mar 19, 2010 (M2 PRESSWIRE via COMTEX) --

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a commu Read More >>

ImmunoGen, Inc. Announces Webcast of Presentation at the 2010 Barclays Capital Global Healthcare Conference

March 18, 2010
WALTHAM, Mass., Mar 18, 2010 (BUSINESS WIRE) --

ImmunoGen, Inc. (Nasdaq: IMGN) is scheduled to present at the 2010 Barclays Capital Global Healthcare Conference at 3:45 pm E Read More >>

SmarTrend Detects Continued Selling Pressure in Shares of Immunogen (IMGN)

March 11, 2010
Mar 11, 2010 (SmarTrend(R) Spotlight via COMTEX) --

SmarTrend identified a Downtrend for Immunogen (NASDAQ:IMGN) on January 08, 2010 at $7.87. In approximately 2 months, Immunogen has returned 5.5% Read More >>

BiomedReports: News and FDA Updates for Golf Trust (NYSE:GTA), Inhibitex (Nasdaq:INHX), ImmunoGen (Nasdaq:IMGN)

March 09, 2010
Pasadena, CA, Mar 09, 2010 (M2 PRESSWIRE via COMTEX) --

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a commu Read More >>

Immunogen Inc. Is Climbing On FDA News

March 08, 2010
(RTTNews) - Immunogen Inc. (IMGN) announced after the close Monday that the FDA granted orphan drug designation to its IMGN901 compound, when used for the treatment of Merkel cell carcinoma. The stock Read More >>

ImmunoGen, Inc. Announces Orphan Drug Designation Granted to IMGN901 for Treatment of Merkel Cell Carcinoma by US FDA and EU COM

March 08, 2010
WALTHAM, Mass., Mar 08, 2010 (BUSINESS WIRE) --

ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products using its antibody experti Read More >>

Conference Calls Today: 2-2:05 P.M. EST

March 03, 2010
Mar 03, 2010 (FinancialWire via COMTEX) --

(Comment on this article at http://www.financialwire.net/2010/03/03/conference-calls-today-2-205-p-m-est/)

March 3, 2010 (FinancialWire) (Investr Read More >>

BiomedReports: News and FDA Updates for Ferro (NYSE:FOE), ImmunoGen (Nasdaq:IMGN), Human Genome Sciences (NASDAQ:HGSI)

March 02, 2010
Pasadena, CA, Mar 02, 2010 (M2 PRESSWIRE via COMTEX) --

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a commu Read More >>

ImmunoGen, Inc. Announces Webcast of Presentations at Upcoming Investor Conferences

March 01, 2010
WALTHAM, Mass., Mar 01, 2010 (BUSINESS WIRE) --

ImmunoGen, Inc. (Nasdaq: IMGN) announced today that management will participate in two upcoming investor conferences with liv Read More >>

SmarTrend Detects Continued Selling Pressure in Shares of Immunogen (IMGN)

February 26, 2010
Feb 26, 2010 (SmarTrend(R) Spotlight via COMTEX) --

SmarTrend identified a Downtrend for Immunogen (NASDAQ:IMGN) on January 08, 2010 at $7.87. In approximately 2 months, Immunogen has returned 17.8 Read More >>

Downtrend Spotted in Shares of Immunogen (IMGN)

February 18, 2010
Feb 18, 2010 (SmarTrend(R) Spotlight via COMTEX) --

SmarTrend identified a Downtrend for Immunogen (NASDAQ:IMGN) on January 08, 2010 at $7.87. In approximately 1 month, Immunogen has returned 12.1% Read More >>

SmarTrend's Trend Spotter See Continued Downward Momentum on Shares of Immunogen (IMGN)

February 11, 2010
Feb 11, 2010 (SmarTrend(R) Spotlight via COMTEX) --

SmarTrend identified a Downtrend for Immunogen (NASDAQ:IMGN) on January 08, 2010 at $7.87. In approximately 1 month, Immunogen has returned 17.7% Read More >>

Immunogen: The Trend Continues Down (IMGN)

February 04, 2010
Feb 04, 2010 (SmarTrend(R) Spotlight via COMTEX) --

SmarTrend identified a Downtrend for Immunogen (NASDAQ:IMGN) on January 08, 2010 at $7.87. In approximately 4 weeks, Immunogen has returned 17.2% Read More >>

BiomedReports: News and FDA Updates for ImmunoGen (Nasdaq:IMGN), ImmunoGen (Nasdaq:IMGN), MedLink (OTC:MLKNA)

February 04, 2010
Pasadena, CA, Feb 04, 2010 (M2 PRESSWIRE via COMTEX) --

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a commu Read More >>

ImmunoGen, Inc. Announces Webcast of its Investment Community Meeting on February 25, 2010

February 03, 2010
WALTHAM, Mass., Feb 03, 2010 (BUSINESS WIRE) --

ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceuticals company that develops targeted anticancer therapeutics using its Targete Read More >>

ImmunoGen, Inc. Announces Webcast of Presentation at the 12th Annual BIO CEO & Investor Conference

February 02, 2010
WALTHAM, Mass., Feb 02, 2010 (BUSINESS WIRE) --

ImmunoGen, Inc. (Nasdaq: IMGN) is scheduled to present at the 12th Annual BIO CEO & Investor Conference at 2:30 pm ET on Read More >>

ImmunoGen Schedules Conference Call to Discuss Second Quarter Fiscal Year 2010 Financial Results

January 31, 2010
Jan 25, 2010 (Close-Up Media via COMTEX) --

ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products, announced that will host a conference call at 4:30p.m. ET on Thursda Read More >>

ImmunoGen, Inc. (IMGN) Corporate Event Announcement Notice

January 29, 2010
Jan 29, 2010 (Wall Street Horizon via COMTEX) -- 
ImmunoGen, Inc. (IMGN)


Expected next earnings release:

Announcement date: 4/29/2010 - After Market

Earnings Quarter: Q3

Announcemen
          
            Read More
            >>

ImmunoGen Inc reports increased Q2 loss

January 29, 2010
Jan 29, 2010 (M2 EQUITYBITES via COMTEX) --

Biotechnology company ImmunoGen Inc (Nasdaq:IMGN) reported on Thursday a net loss of USD13.0m or USD0.23 per basic and diluted share for the second qua Read More >>

ImmunoGen, Inc. (IMGN) Corporate Event Announcement Notice

January 28, 2010
Jan 28, 2010 (Wall Street Horizon via COMTEX) -- 
ImmunoGen, Inc. (IMGN)


Expected next earnings release:

Announcement date: 1/28/2010 - After Market

Earnings Quarter: Q2

Announcemen
          
            Read More
            >>

ImmunoGen, Inc. Reports Second Quarter Fiscal Year 2010 Financial Results

January 28, 2010
WALTHAM, Mass., Jan 28, 2010 (BUSINESS WIRE) --

ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products using its antibody expertise and T Read More >>

SmarTrend's Trend Spotter See Continued Downward Momentum on Shares of Immunogen (IMGN)

January 28, 2010
Jan 28, 2010 (SmarTrend(R) Spotlight via COMTEX) --

SmarTrend identified a Downtrend for Immunogen (NASDAQ:IMGN) on January 08, 2010 at $7.87. In approximately 3 weeks, Immunogen has returned 9.5% Read More >>

Conference Calls Today: 4:30 P.M. EST

January 28, 2010
Jan 28, 2010 (FinancialWire via COMTEX) --

(Comment on this article at http://www.financialwire.net/2010/01/28/conference-calls-today-430-p-m-est-2/)

January 28, 2010 (FinancialWire) (Inve Read More >>

BUYINS.NET: LANC, IMGN, LG, DLLR, COHR, ISCA Expected To Be Higher After Earnings Releases on Thursday

January 27, 2010
Jan 27, 2010 (M2 PRESSWIRE via COMTEX) --

BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, January 28th and determining how the Read More >>

ImmunoGen, Inc. (IMGN) Corporate Event Announcement Notice

January 26, 2010
Jan 26, 2010 (Wall Street Horizon via COMTEX) -- 
ImmunoGen, Inc. (IMGN)


Expected next earnings release:

Announcement date: 1/28/2010 - After Market

Earnings Quarter: Q2

Announcemen
          
            Read More
            >>

ImmunoGen, Inc. (IMGN) Corporate Event Announcement Notice

January 25, 2010
Jan 25, 2010 (Wall Street Horizon via COMTEX) -- 
ImmunoGen, Inc. (IMGN)


Expected next earnings release:

Announcement date: 1/28/2010 - After Market

Earnings Quarter: Q2

Announcemen
          
            Read More
            >>

Brean Murray, Carret & Co. Announces 2010 Healthcare 1x1 Conference

January 25, 2010
NEW YORK, Jan 25, 2010 /PRNewswire via COMTEX/ --

Brean Murray, Carret & Co. will hold its 2010 Healthcare 1x1 Conference on Monday, March 1st in Boston at the Hilton Financial District. The Read More >>

ImmunoGen Schedules Conference Call to Discuss Second Quarter Fiscal Year 2010 Financial Results

January 24, 2010
Jan 25, 2010 (Close-Up Media via COMTEX) --

ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products, announced that will host a conference call at 4:30p.m. ET on Thursda Read More >>

ImmunoGen, Inc. (IMGN) Corporate Event Announcement Notice

January 22, 2010
Jan 22, 2010 (Wall Street Horizon via COMTEX) -- 
ImmunoGen, Inc. (IMGN)


Expected next earnings release:

Announcement date: 1/28/2010 - After Market

Earnings Quarter: Q2

Announcemen
          
            Read More
            >>

ImmunoGen, Inc. (IMGN) Corporate Event Announcement Notice

January 21, 2010
Jan 21, 2010 (Wall Street Horizon via COMTEX) -- 
ImmunoGen, Inc. (IMGN)


Expected next earnings release:

Announcement date: 1/28/2010 - After Market

Earnings Quarter: Q2

Announcemen
          
            Read More
            >>

Fastmoneytalk.com: Smokefree Innotec, Inc. & ImmunoGen, Inc. Profiled by FastMoneyTalk.com

January 21, 2010
Boston, MA, Jan 21, 2010 (M2 PRESSWIRE via COMTEX) --

Smokefree Innotec, Inc. (PINKSHEETS: SFIO); ImmunoGen, Inc. (Nasdaq: IMGN)

FastMoneyTalk.com is part of Stock Profiler.US, LLC's News D Read More >>

ImmunoGen, Inc. Announces Conference Call to Discuss Its Second Quarter Fiscal Year 2010 Financial Results

January 21, 2010
WALTHAM, Mass., Jan 21, 2010 (BUSINESS WIRE) --

ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products, today announced that will host a Read More >>

Immunogen: The Trend Continues Lower (IMGN)

January 20, 2010
Jan 20, 2010 (SmarTrend(R) Spotlight via COMTEX) --

SmarTrend identified a Downtrend for Immunogen (NASDAQ:IMGN) on January 08, 2010 at $7.87. In approximately 2 weeks, Immunogen has returned 4.8% Read More >>

BiomedReports: News and FDA Updates for Halozyme (Nasdaq:HALO), Human Genome (NASDAQ:HGSI), ImmunoGen (Nasdaq:IMGN)

January 07, 2010
Pasadena, CA, Jan 07, 2010 (M2 PRESSWIRE via COMTEX) --

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a commu Read More >>

Thewallstreetleader.com: TheWallStreetLeader.com: Profiles Smokefree Innotec, Inc. & ImmunoGen, Inc.

January 07, 2010
Boston, MA, Jan 07, 2010 (M2 PRESSWIRE via COMTEX) --

Smokefree Innotec, Inc. (PINKSHEETS: SFIO); ImmunoGen, Inc. (Nasdaq: IMGN)

TheWallStreetLeader.com is part of Stock Profiler.US, LLC's Read More >>

ImmunoGen, Inc. Announces Webcast of Presentation at the 28th Annual J.P. Morgan Healthcare Conference

January 06, 2010
WALTHAM, Mass., Jan 06, 2010 (BUSINESS WIRE) --

ImmunoGen, Inc. (Nasdaq: IMGN) is scheduled to present at the 28th Annual J.P. Morgan Healthcare Conference at 9:30 am PST on January Read More >>

Lower Opening For Broader Markets

December 29, 2009
Stocks appear set to open lower Monday Read More >>

TradingMarkets' 10 Stocks You Need To Know About This Morning

TradingMarkets Research - December 29, 2009
Start your trading day right here. Read More >>

BiomedReports: News and FDA Updates for ICON (NASDAQ:ICLR), ImmunoGen (Nasdaq:IMGN), Ligand (NASDAQ:LGND), Neurogen (NASDAQ:NRGN

December 29, 2009
Pasadena, CA, Dec 18, 2009 (M2 PRESSWIRE via COMTEX) -- NRGN | Quote | Chart | News | PowerRating -- BioMedReports.Com, the news portal which covers Wall Streets biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare st Read More >>

ImmunoGen, Inc. Appoints Suzanne Cadden as Vice President, Regulatory Affairs & Quality

December 29, 2009
WALTHAM, Mass., Dec 17, 2009 (BUSINESS WIRE) -- IMGN | Quote | Chart | News | PowerRating -- ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products, announced today the appointment of Suzanne Cadden as Vice President of Regul Read More >>

ImmunoGen Conference Call Today, 8 A.M.

December 29, 2009
Dec 14, 2009 (FinancialWire via COMTEX) -- IMGN | Quote | Chart | News | PowerRating -- (Comment on this article at http://www.financialwire.net/2009/12/14/immunogen-conference-call-today-8-a-m/)December 14, 2009 (FinancialWire) (Investrend Broadcast Syndicate) -- BestCalls will broadcast th Read More >>

ImmunoGen, Inc. Announces Positive Trastuzumab-DM1 Clinical Data Reported at the San Antonio Breast Cancer Symposium

December 29, 2009
WALTHAM, Mass., Dec 12, 2009 (BUSINESS WIRE) -- IMGN | Quote | Chart | News | PowerRating -- ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops targeted anticancer therapeutics, today announced the presentation of positive trastuzumab-DM1 (T-DM1) clini Read More >>

Immunogen Up 11.4% Since SmarTrend's Buy Recommendation

December 29, 2009
Dec 10, 2009 (SmarTrend(R) Spotlight via COMTEX) -- IMGN | Quote | Chart | News | PowerRating -- SmarTrend, our proprietary pattern recognition system, called an Uptrend for Immunogen (NASDAQ:IMGN) on November 09, 2009 at $8.19.In roughly 1 month, Immunogen has returned 11.4% as of todays re Read More >>

ImmunoGen Presents SAR3419 Phase I Study Results in non-Hodgkin's Lymphoma at ASH

December 29, 2009
Dec 10, 2009 (Close-Up Media via COMTEX) -- IMGN | Quote | Chart | News | PowerRating -- ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced the presentation of encouraging initial clinical findings with SAR3419 at the American Society of Hem Read More >>

BiomedReports: News and FDA Updates for ImmunoGen (Nasdaq:IMGN), Alexion (Nasdaq:ALXN), ICON (NASDAQ:ICLR)

December 29, 2009
Pasadena, CA, Dec 08, 2009 (M2 PRESSWIRE via COMTEX) -- IMGN | Quote | Chart | News | PowerRating -- BioMedReports.Com, the news portal which covers Wall Streets biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare st Read More >>

SAR3419 Phase I Study Results in non-Hodgkin's Lymphoma at ASH

December 29, 2009
WALTHAM, Mass., Dec 07, 2009 (BUSINESS WIRE) -- IMGN | Quote | Chart | News | PowerRating -- ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops targeted anticancer therapeutics, today announced the presentation of encouraging initial clinical findings Read More >>

ImmunoGen, Inc. Announces Encouraging Clinical Data with Its IMGN901 Compound in the Treatment of Multiple Myeloma

December 29, 2009
WALTHAM, Mass., Dec 06, 2009 (BUSINESS WIRE) -- IMGN | Quote | Chart | News | PowerRating -- ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops targeted anticancer therapeutics, today reported encouraging clinical data with its IMGN901 product candidat Read More >>

BiomedReports: News and FDA Updates for ImmunoGen (Nasdaq:IMGN), Jazz Pharma (Nasdaq:JAZZ), Kyto (OTC:KBPH)

December 29, 2009
Pasadena, CA, Dec 04, 2009 (M2 PRESSWIRE via COMTEX) -- KBPH | Quote | Chart | News | PowerRating -- BioMedReports.Com, the news portal which covers Wall Streets biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare st Read More >>

ImmunoGen, Inc. Announces Conference Call to Discuss Clinical Data Reported at Recent Medical Meetings

December 29, 2009
WALTHAM, Mass., Dec 03, 2009 (BUSINESS WIRE) -- IMGN | Quote | Chart | News | PowerRating -- ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products, today announced that the Company will hold a conference call at 8:00 a.m. ET on Mo Read More >>

ImmunoGen to Present at Upcoming ASH Annual Meeting and Exposition

December 29, 2009
Dec 01, 2009 (Close-Up Media via COMTEX) -- IMGN | Quote | Chart | News | PowerRating -- ImmunoGen, Inc., a biopharmaceutical company that develops targeted anticancer therapeutics, announced that presentations of clinical data for three product candidates employing its Targeted Antibody Payl Read More >>

UPCOMING EVENTS
Learn new strategies, how to trade in this market, and the stocks you should be focusing on each day. Join us for our free 20 minute tele-seminars during the week.
Thursday March 25 04:30 PM
The TradingMarkets Swing Trading College Presentation
Thursday March 25 12:30 PM
Hear What Kevin Haggerty Sees in the Stock Market Today!
Wednesday March 24 01:00 PM
Hear What Gary Kaltbaum Sees in the Stock Market Today!
* Attendance is strictly limited and are filled on a first-come, first-served basis.
TM News Letter Free News Letters
Free newsletters by the TradingMarkets editorial team.

Morning Coffee with TradingMarkets
Larry Connors Trading Lesson of the Day
7 Stocks You Need To Know For Tomorrow
TradingMarkets Weekly Newsletter
PowerRatings Newsletter
Most Overbought and Oversold ETFs
7 ETF's You Need to Know

Subscribe